In our multicentre , partial-factorial trial , we randomly assigned patients admitted to hospital with an acute ischaemic or haemorrhagic stroke and raised systolic blood pressure ( systolic @-@ mm Hg ) to @ days of transdermal glyceryl trinitrate ( @ mg per day ) , started within @ h of stroke onset , or to no glyceryl trinitrate ( control group ) .